Pharmaceutical Technology Europe, August 2022
Recently, there have been some high-profile product recalls within the pharmaceutical industry in which nitrosamines were detected. It’s important now, more than ever, that drug manufacturers are screening for apparent total nitrosamine content. This article looks at a thermal energy analyser and how it offers a rapid way of identifying contaminated drug products. Read the full article here.
A. James, “Detecting Apparent Total Nitrosamine Content in Pharmaceutical Drugs”, Pharmaceutical Technology Europe 34 (8) 2022, pages: 29–31.